DK Life Science Statistics

Total Valuation

DK Life Science has a market cap or net worth of KRW 146.65 billion.

Market Cap	146.65B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

DK Life Science has 15.99 million shares outstanding.

Current Share Class	15.99M
Shares Outstanding	15.99M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.55%
Owned by Institutions (%)	n/a
Float	3.81M

Valuation Ratios

The trailing PE ratio is 38.57.

PE Ratio	38.57
Forward PE	n/a
PS Ratio	1.10
PB Ratio	1.17
P/TBV Ratio	1.23
P/FCF Ratio	46.32
P/OCF Ratio	17.80
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.35.

Current Ratio	2.34
Quick Ratio	1.68
Debt / Equity	0.35
Debt / EBITDA	2.43
Debt / FCF	13.90
Interest Coverage	4.96

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	8.17%
Revenue Per Employee	1.33B
Profits Per Employee	38.02M
Employee Count	100
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DK Life Science has paid 2.61 billion in taxes.

Income Tax	2.61B
Effective Tax Rate	40.75%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	9,397.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	40.13
Average Volume (20 Days)	95,282

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DK Life Science had revenue of KRW 133.30 billion and earned 3.80 billion in profits. Earnings per share was 277.14.

Revenue	133.30B
Gross Profit	28.89B
Operating Income	12.15B
Pretax Income	6.42B
Net Income	3.80B
EBITDA	18.15B
EBIT	12.15B
Earnings Per Share (EPS)	277.14

Balance Sheet

The company has 18.09 billion in cash and 44.02 billion in debt, giving a net cash position of -25.92 billion or -1,620.99 per share.

Cash & Cash Equivalents	18.09B
Total Debt	44.02B
Net Cash	-25.92B
Net Cash Per Share	-1,620.99
Equity (Book Value)	125.27B
Book Value Per Share	7,832.96
Working Capital	73.00B

Cash Flow

In the last 12 months, operating cash flow was 8.24 billion and capital expenditures -5.07 billion, giving a free cash flow of 3.17 billion.

Operating Cash Flow	8.24B
Capital Expenditures	-5.07B
Free Cash Flow	3.17B
FCF Per Share	197.96

Margins

Gross margin is 21.67%, with operating and profit margins of 9.11% and 2.85%.

Gross Margin	21.67%
Operating Margin	9.11%
Pretax Margin	4.81%
Profit Margin	2.85%
EBITDA Margin	13.61%
EBIT Margin	9.11%
FCF Margin	2.37%

Dividends & Yields

DK Life Science does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.59%
FCF Yield	2.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DK Life Science has an Altman Z-Score of 2.9 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.9
Piotroski F-Score	3